GS LHF 75 mg Pill: pink, capsule/oblong, 20mm
Generic Name: dabrafenib
The pill with imprint GS LHF 75 mg (Pink, Capsule/Oblong, 20mm) has been identified as Tafinlar 75 mg and is used for Melanoma, Metastatic, Thyroid Cancer, Non Small Cell Lung Cancer, Low-Grade Glioma, and Solid Tumors. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for GS LHF 75 mg
Tafinlar
- Generic Name
- dabrafenib
- Imprint
- GS LHF 75 mg
- Strength
- 75 mg
- Color
- Pink
- Size
- 20.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
hypromelloses,
ferric oxide red,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00078-0681 | Novartis Pharmaceuticals Corporation |
| 00173-0847 (Discontinued) | GlaxoSmithKline |
See also:
More about Tafinlar (dabrafenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.